Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
What Every Man Should Know About Prostate Cancer -- a Leading Cause of Death
Prostate cancer screening can help detect signs of cancer before symptoms start. It’s essential for men to talk with their doctor about the pros and cons of screening and what’s right for them.
Cancer Q&A with HOA: what to know about prostate cancer
This year, it is estimated that nearly 300,000 men will get diagnosed with prostate cancer in the United States alone. However, survival rates are extremely high, if the cancer is detected early
Theranostics a ‘State-of-the-Art’ Treatment Option for Prostate Cancer
For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who need more options.
Ultrasound technology makes prostate cancer diagnosis & treatment easier
Follow-up tests included a prostate MRI, which showed a suspicious spot for cancer on one side of the prostate. An image-guided, targeted biopsy confirmed this area to be prostate cancer of an intermediate grade. Fortunately, Bellanti was eligible for the HIFU procedure.
How to detect prostate cancer early
Kaiser Permanente Family Medicine Physician Dr. Josh Wilner discusses the steps men can take to detect prostate cancer early.
When Prostate Cancer Isn't Really 'Cancer'
A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients may benefit if doctors stop calling certain early-stage changes to the prosta
Prostate Cancer: Know About Risk Factors, Early Detections, Treatments And More
The risk of prostate cancer rises very steeply with age and as per the CDC, 66% of cases are reported in males above 65 yr of
WVTM 13 Birmingham on MSN
2h
Prostate cancer alert: Birmingham doctor urges earlier screenings
A Birmingham-area doctor is sharing the importance of early screening and detection for Prostate cancer.It's the most common ...
FiercePharma
1d
J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study
While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi ...
Medscape
23h
Adding EBRT to Brachytherapy Did Not Improve Higher-Risk Prostate Cancer Outcomes
Adding external beam radiotherapy did not improve biochemical failure outcomes or prostate cancer specific mortality in ...
Rolling Out
2d
5 steps to take immediately after a prostate cancer diagnosis
Receiving a prostate cancer diagnosis can be life-altering, both mentally and physically. It's a moment filled with ...
40m
Peddle4Prostate: Te Ururoa Flavell goes from planning his own tangi to fronting prostate cancer head-on
Former MP Te Ururoa Flavell - who was diagnosed with prostate cancer last year - has gone from planning his own tangi to ...
2d
Experts suggest stripping ‘cancer’ from low-grade prostate cancer diagnoses
Cancer doctors, scientists, and patient advocates said the “cancer” label can do more harm than good, given this form of the ...
American Cancer Society
3d
Cancer in Men: Prostate Cancer is #1 for 118 Countries Globally
Prostate cancer is the most commonly diagnosed cancer in males in 118 of 185 countries, but it's the leading cause of death ...
6d
Early detection and knowing risk factors are key to beating prostate cancer
HOUSTON — September is Prostate Cancer Awareness Month. One in eight men will be diagnosed during their lifetime, and it's ...
Renal & Urology News
4h
MRI Predicts Prostate Cancer Upgrading at First Active Surveillance Biopsy
MRI around the time of diagnostic biopsy may identify patients at increased risk for early reclassification during prostate cancer active surveillance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Erleada
Radiation therapy
Enzalutamide
Johnson & Johnson
Astellas Pharma
Feedback